Company Filing History:
Years Active: 2018-2023
Title: Michelle Baron: Innovator in GLP-1 Analog Administration
Introduction
Michelle Baron is a prominent inventor based in Boston, MA (US), known for her significant contributions to the field of drug administration. With a total of four patents to her name, she has made remarkable strides in the development of methods for administering glucagon-like peptide-1 (GLP-1) analogs.
Latest Patents
Among her latest patents, Michelle has developed methods comprising continuous administration of exenatide and co-administration of a drug. This innovative method allows for the continuous subcutaneous dosing of GLP-1 analogs via an implantable delivery device, while also enabling the oral co-administration of a drug after the device's implantation. Another notable patent involves similar methods for administering a GLP-1 receptor agonist, showcasing her dedication to improving therapeutic approaches in this area.
Career Highlights
Throughout her career, Michelle has worked with notable companies such as Intarcia Therapeutics, Inc. and I2o Therapeutics, Inc. Her work in these organizations has contributed to advancements in drug delivery systems and patient care.
Collaborations
Michelle has collaborated with esteemed colleagues, including Thomas R. Alessi and Andrew A. Young, further enhancing her innovative efforts in the field.
Conclusion
Michelle Baron stands out as a leading inventor in the realm of GLP-1 analog administration. Her patents and collaborations reflect her commitment to advancing medical technology and improving patient outcomes.